» Articles » PMID: 15731379

Large-scale Conformational Dynamics of the HIV-1 Integrase Core Domain and Its Catalytic Loop Mutants

Overview
Journal Biophys J
Publisher Cell Press
Specialty Biophysics
Date 2005 Feb 26
PMID 15731379
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

HIV-1 integrase is one of the three essential enzymes required for viral replication and has great potential as a novel target for anti-HIV drugs. Although tremendous efforts have been devoted to understanding this protein, the conformation of the catalytic core domain around the active site, particularly the catalytic loop overhanging the active site, is still not well characterized by experimental methods due to its high degree of flexibility. Recent studies have suggested that this conformational dynamics is directly correlated with enzymatic activity, but the details of this dynamics is not known. In this study, we conducted a series of extended-time molecular dynamics simulations and locally enhanced sampling simulations of the wild-type and three loop hinge mutants to investigate the conformational dynamics of the core domain. A combined total of >480 ns of simulation data was collected which allowed us to study the conformational changes that were not possible to observe in the previously reported short-time molecular dynamics simulations. Among the main findings are a major conformational change (>20 A) in the catalytic loop, which revealed a gatinglike dynamics, and a transient intraloop structure, which provided a rationale for the mutational effects of several residues on the loop including Q(148), P(145), and Y(143). Further, clustering analyses have identified seven major conformational states of the wild-type catalytic loop. Their implications for catalytic function and ligand interaction are discussed. The findings reported here provide a detailed view of the active site conformational dynamics and should be useful for structure-based inhibitor design for integrase.

Citing Articles

Computing the Structural Dynamics of RVFV L Protein Domain in Aqueous Glycerol Solutions.

Gogovi G, Silayi S, Shehu A Biomolecules. 2021; 11(10).

PMID: 34680060 PMC: 8533350. DOI: 10.3390/biom11101427.


Evaluation of novel '-(3-hydroxybenzoyl)-2-oxo-2-chromene-3-carbohydrazide derivatives as potential HIV-1 integrase inhibitors.

Jesumoroti O, Faridoon , Mnkandhla D, Isaacs M, Hoppe H, Klein R Medchemcomm. 2019; 10(1):80-88.

PMID: 30774857 PMC: 6350760. DOI: 10.1039/c8md00328a.


Rigidity and flexibility characteristics of DD[E/D]-transposases Mos1 and Sleeping Beauty.

Singer C, Joy D, Jacobs D, Nesmelova I Proteins. 2018; 87(4):313-325.

PMID: 30582767 PMC: 6408976. DOI: 10.1002/prot.25653.


Lysines and Arginines play non-redundant roles in mediating chemokine-glycosaminoglycan interactions.

Joseph P, Sawant K, Iwahara J, Garofalo R, Desai U, Rajarathnam K Sci Rep. 2018; 8(1):12289.

PMID: 30115951 PMC: 6095893. DOI: 10.1038/s41598-018-30697-y.


Chemokine CXCL7 Heterodimers: Structural Insights, CXCR2 Receptor Function, and Glycosaminoglycan Interactions.

Brown A, Joseph P, Sawant K, Rajarathnam K Int J Mol Sci. 2017; 18(4).

PMID: 28368308 PMC: 5412333. DOI: 10.3390/ijms18040748.


References
1.
Duan Y, Wu C, Chowdhury S, Lee M, Xiong G, Zhang W . A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comput Chem. 2003; 24(16):1999-2012. DOI: 10.1002/jcc.10349. View

2.
Lobel L, Murphy J, Goff S . The palindromic LTR-LTR junction of Moloney murine leukemia virus is not an efficient substrate for proviral integration. J Virol. 1989; 63(6):2629-37. PMC: 250744. DOI: 10.1128/JVI.63.6.2629-2637.1989. View

3.
Oliva B, Bates P, Querol E, Aviles F, STERNBERG M . Automated classification of antibody complementarity determining region 3 of the heavy chain (H3) loops into canonical forms and its application to protein structure prediction. J Mol Biol. 1998; 279(5):1193-210. DOI: 10.1006/jmbi.1998.1847. View

4.
Tsurutani N, Kubo M, Maeda Y, Ohashi T, Yamamoto N, Kannagi M . Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells. J Virol. 2000; 74(10):4795-806. PMC: 112002. DOI: 10.1128/jvi.74.10.4795-4806.2000. View

5.
Cannon P, Wilson W, Byles E, Kingsman S, Kingsman A . Human immunodeficiency virus type 1 integrase: effect on viral replication of mutations at highly conserved residues. J Virol. 1994; 68(8):4768-75. PMC: 236416. DOI: 10.1128/JVI.68.8.4768-4775.1994. View